COSTS OF PSORIASIS IN EUROPE. A SYSTEMATIC REVIEW OF THE LITERATURE

Author(s)

Obradors M1, Figueras M1, Paz S2, Comellas M2, Lizán L2
1Novartis Farmaceutica S.A., Barcelona, Spain, 2Outcomes'10, Castellon, Spain

OBJECTIVES To appraise the literature referred to direct and indirect costs of psoriasis in Europe.   METHODS A systematic review of the literature was performed. Electronic databases [MedLine/PubMed, Scopus, Cochrane Library, ISI Wok, MEDES, IBECS, CSIC] and Google Scholar were searched to identify publications referred to direct and indirect costs of psoriasis in Europe. Bibliographic references were hand searched. European studies published in English or Spanish until October 2013 were selected. Economic evaluations of specific drugs and of preventive or diagnostic interventions were excluded. Costs were updated to €,2013. RESULTS

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PSS14

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Sensory System Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×